Post-approval studies (Phase 4)Study completedNCT03346772What this trial is testingStudy of Immune Responses to Influenza VaccinationWho this might be right forInfluenza Vaccination University of Pennsylvania 150
Large-scale testing (Phase 3)Study completedNCT00753272What this trial is testingTrial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and OlderWho this might be right forInfluenza GlaxoSmithKline 43,695
Not applicableStudy completedNCT01224301What this trial is testingSchool Influenza Vaccine vs Standard of Care With Nested Trial of 2 Parent Notification IntensitiesWho this might be right forImmunizationsVaccinationInfluenza+1 more Monroe County Department of Public Health 25,366
Post-approval studies (Phase 4)Study completedNCT02592486What this trial is testingThe Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal VaccineWho this might be right forPneumococcal PneumoniaInfluenza Kameda Medical Center 162
Large-scale testing (Phase 3)Study completedNCT02369341What this trial is testingImmunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and AboveWho this might be right forInfluenza GlaxoSmithKline 121
Post-approval studies (Phase 4)Study completedNCT02972957What this trial is testingIntranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the GambiaWho this might be right forInfluenza London School of Hygiene and Tropical Medicine 364
Large-scale testing (Phase 3)Study completedNCT01448057What this trial is testingEvaluation of Efficacy and Safety of Tablets of Paracetamol, Dimethindene Maleate and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and FluWho this might be right forUpper Respiratory Tract InfectionNasal CongestionRhinorrhea+1 more Novartis 341
Post-approval studies (Phase 4)Study completedNCT01691339What this trial is testingStudy of Fluzone® Influenza Virus Vaccines 2012-2013 Formulation Among Adults.Who this might be right forInfluenza Sanofi Pasteur, a Sanofi Company 200
Testing effectiveness (Phase 2)Study completedNCT04956575What this trial is testingMRNA-1010 Seasonal Influenza Vaccine in Healthy AdultsWho this might be right forSeasonal Influenza ModernaTX, Inc. 885
Not applicableStudy completedNCT00001681What this trial is testingA Pilot Study of the Patterns of Cellular Gene Expression in HIV-1 Patients Following Clinical Events Which Increase Plasma Virus ConcentrationsWho this might be right forHIV Infections National Cancer Institute (NCI) 40
Post-approval studies (Phase 4)Study completedNCT03266237What this trial is testingThe Immune Response to Influenza Vaccinations in Elderly IndividualsWho this might be right forInfluenza National University Hospital, Singapore 240
Early research (Phase 1)Study completedNCT00984945What this trial is testingSafety Study of a Plant-based H5 Virus-Like Particles (VLP) Vaccine in Healthy AdultsWho this might be right forVirus DiseasesRNA Virus InfectionsRespiratory Tract Diseases+1 more Medicago 48
Early research (Phase 1)Study completedNCT01855945What this trial is testingSafety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.Who this might be right forProphylaxis of A/H3N2v Influenza Novartis Vaccines 627
Not applicableStudy completedNCT02632578What this trial is testingInfluenza Vaccine in HIV StudyWho this might be right forInfluenza, Human University of Melbourne 57
Testing effectiveness (Phase 2)Looking for participantsNCT05648448What this trial is testingTrial Comparing Antiviral Treatments in Early Symptomatic InfluenzaWho this might be right forInfluenzaInfluenza, Human University of Oxford 3,000
Early research (Phase 1)Study completedNCT01236040What this trial is testingImmunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years OldWho this might be right forInfluenza GlaxoSmithKline 521
Not applicableUnknownNCT02009735What this trial is testingVirosensor -Based Real-time Diagnosis of Enterovirus 71 and Influenza VirusWho this might be right forEnterovirus 71 and Influenza Virus National Taiwan University Hospital 600
Not applicableStudy completedNCT06668025What this trial is testingMxA-Guided Antiviral Treatment in Respiratory Viral InfectionsWho this might be right forRespiratory Viral InfectionsInfluenzaSARS CoV-2 Capital Medical University 86
Post-approval studies (Phase 4)Study completedNCT01001026What this trial is testingRapid Evaluation of Pandemic H1N1 Influenza Vaccine in Aboriginal Children and AdultsWho this might be right forH1N1/2009 Influenza David Scheifele 156
Not applicableStudy completedNCT04110366What this trial is testingNasal and Systemic Immune Responses to Nasal Influenza VaccineWho this might be right forInfluenzaVaccine Virus Shedding Imperial College Healthcare NHS Trust 48